Prognostic association of plasma cell free DNA based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration resistant prostate cancer patients

BACKGROUND: The prognostic significance of plasma cell-free DNA (cfDNA) androgen receptor amplification (ARamp) in metastatic castration resistant prostate cancer (mCRPC) compared with circulating tumor cell (CTC) counts is not known. METHODS: As part of correlative aims of a prospective study in mC...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohli, Manish, Li, Jian, Du, Meijun, Hillman, David, Dehm, Scott M., Tan, Winston, Carlson, Rachel, Campion, Michael B., Wang, Liguo, Wang, Liewei, Zhang, Huijuan, Zhang, Peng, Kilari, Deepak, Huang, Chiang-Ching, Wang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126974/
https://www.ncbi.nlm.nih.gov/pubmed/29858592
http://dx.doi.org/10.1038/s41391-018-0043-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126974/
https://www.ncbi.nlm.nih.gov/pubmed/29858592
http://dx.doi.org/10.1038/s41391-018-0043-z

Ejemplares similares